The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
Phones:
+7 (495) 482-4118
+7 (495) 482-4329
  • Toll-free number for subscriptions:
    +8 800 250-18-12
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Mogil’nitskaya L.A.

Khmel’nitsk Regional Hospital, Ukraine

Serum fibronectin content in the patients suffering from type 1 diabetes mellitus with microangiopathies since the childhood and in the subjects presenting with obesity

Authors:

Mogil’nitskaya L.A.

More about the authors

Journal: Problems of Endocrinology. 2015;61(1): 36‑40

DOI: 10.14341/probl201561136-40

Read: 933 times

Contact the author
Table of contents

SERUM FIBRONECTIN CONTENT IN THE PATIENTS SUFFERING FROM TYPE 1 DIABETES MELLITUS WITH MICROANGIOPATHIES SINCE THE CHILDHOOD AND IN THE SUBJECTS PRESENTING WITH OBESITY
SERUM FIBRONECTIN CONTENT IN THE PATIENTS SUFFERING FROM TYPE 1 DIABETES MELLITUS WITH MICROANGIOPATHIES SINCE THE CHILDHOOD AND IN THE SUBJECTS PRESENTING WITH OBESITY

To cite this article:

Mogil’nitskaya LA. Serum fibronectin content in the patients suffering from type 1 diabetes mellitus with microangiopathies since the childhood and in the subjects presenting with obesity. Problems of Endocrinology. 2015;61(1):36‑40. (In Russ.)
https://doi.org/10.14341/probl201561136-40

МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Sarcopenia index for dete­cting of the decreased muscle stre­ngth and mass in patients with the non-alcoholic fatty liver disease. Russian Journal of Preventive Medi­cine. 2025;(7):68-74
Ethnic aspe­cts of risk factors for the type 2 diabetes mellitus deve­lopment in the overweight women of the Pribaikalsky region. Russian Journal of Preventive Medi­cine. 2025;(8):56-62
Study of the consistency and vali­dity of the Russian version Adult Eating Beha­viour Questionnaire. Russian Journal of Preventive Medi­cine. 2025;(8):89-95
Chro­nic kidney disease and microcirculation diso­rders. Russian Journal of Preventive Medi­cine. 2025;(8):123-130
The type 1 diabetes mellitus treatment. Russian Journal of Preventive Medi­cine. 2025;(8):131-137
Obesity and musculoskeletal pain: possibilities of pharmacotherapy. A narrative overview. Russian Journal of Pain. 2025;(3):73-81
Staffing resources solu­tions for patients with obesity healthcare enha­ncement. Russian Journal of Preventive Medi­cine. 2025;(9):42-46
Effe­cts of sema­glutide on mental health. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(9):28-36
Mito­chondrial cyto­protectors in complex therapy of chro­nic heart failure in patients with meta­bolic syndrome or type 2 diabetes mellitus: suba­nalysis of the INDI­KOR study. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(5):566-576
«Metabolic health» and endo­thelial function in women with poly­cystic ovary syndrome. Russian Bulletin of Obstetrician-Gynecologist. 2025;(5):27-34
Abstract:

Micro- and macroangiopathies are the main causes of disability and mortality among the patients suffering from diabetes mellitus. Endothelial dysfunction is the early and important condition preceding the development of diabetic angiopathies. The serum fibronectin content may be one of the markers of endothelial dysfunction. We have documented the enhanced serum fibronectin content in the patients suffering from type 1 diabetes mellitus with concomitant microangiopathies and in the subjects presenting with obesity. The rise in the serum fibronectin level correlated with the body mass index, parameters of carbohydrate and lipid metabolism. Alteration of these parameters discovered in the present study may be used as the markers of endothelial dysfunction associated with the above pathological conditions.

Keywords:

fibronectin
endothelial dysfunction
type 1 diabetes mellitus
microangiopathies
obesity

Authors:

Mogil’nitskaya L.A.

Khmel’nitsk Regional Hospital, Ukraine

Close metadata

References:

  1. Larsen J, Brekke M, Sandvik L, et al. Silent Coronary Atheromatosis in Type 1 Diabetic Patients and Its Relation to Long-Term Glycemic Control. Diabetes. 2002;51(8):2637-2641. doi: 10.2337/diabetes.51.8.2637.
  2. Jarvisalo MJ. Endothelial Dysfunction and Increased Arterial Intima-Media Thickness in Children With Type 1 Diabetes. Circulation. 2004;109(14):1750-1755. doi: 10.1161/01.cir.0000124725.46165.2c
  3. Schoenhagen P, Nissen S. Coronary Atherosclerotic Disease Burden: An Emerging Endpoint in Progression / Regression Studies Using Intravascular Ultrasound. Current Drug Target -Cardiovascular & Hematological Disorders. 2003;3(3):218-226. doi: 10.2174/1568006033481401
  4. Caballero AE, Arora S, Saouaf R, et al. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes. 1999;48(9):1856-1862. doi: 10.2337/diabetes.48.9.1856
  5. Williams SB, Cusco JA, Roddy M-A, et al. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J. Am. Coll. Cardiol. 1996;27(3):567-574. doi: 10.1016/0735-1097(95)00522-6.
  6. Hynes RO. Fibronectins. Sci. Am. 1986;254(6):42-51. doi: 10.1038/scientificamerican0686-42
  7. Tomasini-Johansson BR, Annis DS, Mosher DF. The N-terminal 70-kDa fragment of fibronectin binds to cell surface fibronectin assembly sites in the absence of intact fibronectin. Matrix Biol. 2006;25(5):282-293. doi: 10.1016/j.matbio.2006.02.002.
  8. Singh P, Carraher C, Schwarzbauer JE. Assembly of Fibronectin Extracellular Matrix. Annu. Rev. Cell Dev. Biol. 2010;26(1):397-419. doi: 10.1146/annurev-cellbio-100109-104020
  9. Kanters SDJM, Banga JD, Algra A, et al. Plasma Levels of Cellular Fibronectin in Diabetes. Diabetes Care. 2001;24(2):323-327. doi: 10.2337/diacare.24.2.323
  10. Olsen AL, Sackey BK, Marcinkiewicz C, et al. Fibronectin Extra Domain-A Promotes Hepatic Stellate Cell Motility but Not Differentiation Into Myofibroblasts. Gastroenterology. 2012;142(4):928-937.e923. doi: 10.1053/j.gastro.2011.12.038 
  11. Bauters C, Marotte F, Hamon M, et al. Accumulation of Fetal Fibronectin mRNAs After Balloon Denudation of Rabbit Arteri­es. Circulation. 1995;92(4):904-911. doi: 10.1161/01.cir.92.4.904
  12. Habib SL, Yadav M, Tizani S, et al. Tuberin Inhibits Production of the Matrix Protein Fibronectin in Diabetes. J. Am. Soc. Nephrol. 2012;23(10):1652-1662. doi: 10.1681/asn.2012030285
  13. Trudeau K, Roy S, Guo W, et al. Fenofibric Acid Reduces Fibronectin and Collagen Type IV Overexpression in Human Retinal Pigment Epithelial Cells Grown in Conditions Mimicking the Diabetic Milieu: Functional Implications in Retinal Permeability. Invest. Ophthalmol. Vis. Sci. 2011;52(9):6348-6354. doi: 10.1167/iovs.11-7282
  14. Lim Y, Jo DH, Kim JH, et al. Human Apolipoprotein(a) Kringle V Inhibits Ischemia-Induced Retinal Neovascularization via Suppression of Fibronectin-Mediated Angiogenesis. Diabetes. 2012;61(6):1599-1608. doi: 10.2337/db11-1541
  15. Rohwedder I, Montanez E, Beckmann K, et al. Plasma fibronectin deficiency impedes atherosclerosis progression and fibrous cap formation. EMBO Mol. Med. 2012;4(7):564-576. doi: 10.1002/emmm.201200237
  16. Chiang HY, Korshunov VA, Serour A, et al. Fibronectin Is an Important Regulator of Flow-Induced Vascular Remodeling. Arterioscler. Thromb. Vasc. Biol. 2009;29(7):1074-1079. doi: 10.1161/atvbaha.108.181081
  17. Aziz-Seible RS. Fibronectin: Functional character and role in alcoholic liver disease. World J. Gastroenterol. 2011;17(20):2482. doi: 10.3748/wjg.v17.i20.2482
  18. van der Plas RM, Schiphorst ME, Huizinga EG, et al. von Willebrand factor proteolysis is deficient in classic, but not in bone marrow transplantation-associated, thrombotic thrombocytopenic purpura. Blood. 1999;93(11):3798-3802.
  19. van Beers JJBC, Willemze A, Stammen-Vogelzangs J, et al. Anti-citrullinated fibronectin antibodies in rheumatoid arthritis are associated with human leukocyte antigen-DRB1 shared epitope alleles. Arthritis Res. Ther. 2012;14(1):R35. doi: 10.1186/ar3744
  20. Erbey JR, Kuller LH, Becker DJ, Orchard TJ. The Association Between a Family History of Type 2 Diabetes and Coronary Artery Disease in a Type 1 Diabetes Population. Diabetes Care. 1998;21(4):610-614. doi: 10.2337/diacare.21.4.610
  21. Tooke JE. Possible pathophysiological mechanisms for diabetic angiopathy in type 2 diabetes. J. Diabetes Complications. 2000;14(4):197-200. doi: 10.1016/s1056-8727(00)00083-0
  22. Lehto S, Ronnemaa T, Pyorala K, Laakso M. Poor Glycemic Control Predicts Coronary Heart Disease Events in Patients With Type 1 Diabetes Without Nephropathy. Arterioscler. Thromb. Vasc. Biol. 1999;19(4):1014-1019. doi: 10.1161/01.atv.19.4.1014
  23. Adameova A, Dhalla NS. Role of microangiopathy in diabetic cardiomyopathy. Heart Fail. Rev. 2013;19(1):25-33. doi: 10.1007/s10741-013-9378-7
  24. Chillarón JJ, Flores Le-Roux JA, Benaiges D, Pedro-Botet J. Type 1 diabetes, metabolic syndrome and cardiovascular risk. Metabolism. 2014;63(2):181-187. doi: 10.1016/j.metabol.2013.10.002
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.